Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-20 Purchase | 2024-11-21 9:53 pm | Kairos Pharma LTD. | KAPA | Yu John S CEO and Chairman 10% Owner | 4,000 | $1.44 | $5,760 | 5,341,837 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-09-24 9:00 pm | N/A N/A | Kairos Pharma LTD. | KAPA | Bhowmick Neil Chief Scientific Officer | 0 | $0 | 1,125,983 (Direct) | View |
Ownership | 2024-09-24 9:00 pm | N/A N/A | Kairos Pharma LTD. | KAPA | MAZANET ROSEMARY Director | 0 | $0 | 0 (Direct) | View |
Ownership | 2024-09-24 9:00 pm | N/A N/A | Kairos Pharma LTD. | KAPA | Murali Ramachandran VP of Research and Development | 0 | $0 | 132,857 (Direct) | View |
Ownership | 2024-09-24 9:00 pm | N/A N/A | Kairos Pharma LTD. | KAPA | Keyoung Hansoo Michael Director | 0 | $0 | 0 (Direct) | View |
Ownership | 2024-09-24 9:00 pm | N/A N/A | Kairos Pharma LTD. | KAPA | Samuelson Doug Chief Financial Officer | 0 | $0 | 58,296 (Direct) | View |
Ownership | 2024-09-24 9:00 pm | N/A N/A | Kairos Pharma LTD. | KAPA | Yu John S CEO and Chairman 10% Owner | 0 | $0 | 5,337,837 (Direct) | View |
Ownership | 2024-09-24 9:00 pm | N/A N/A | Kairos Pharma LTD. | KAPA | Bae Hyun W. Director | 0 | $0 | 44,286 (Direct) | View |